Cargando…
Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA–Positive Samples( )
While detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by diagnostic reverse-transcription polymerase chain reaction (RT-PCR) is highly sensitive for viral RNA, the nucleic acid amplification of subgenomic RNAs (sgRNAs) that are the product of viral replication may more accu...
Autores principales: | Deming, Meagan E, Dong, Tracy Q, Agrawal, Vaidehi, Mills, Margaret G, Huang, Meei Li W, Greninger, Alexander L, Jerome, Keith R, Wener, Mark H, Paasche-Orlow, Michael K, Kissinger, Patricia, Luk, Alfred, Hoffman, Risa M, Stewart, Jenell, Kottkamp, Angelica C, Bershteyn, Anna, Chu, Helen Y, Stankiewicz Karita, Helen C, Johnston, Christine M, Wald, Anna, Barnabas, Ruanne, Brown, Elizabeth R, Neuzil, Kathleen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903395/ https://www.ncbi.nlm.nih.gov/pubmed/35150571 http://dx.doi.org/10.1093/infdis/jiac048 |
Ejemplares similares
-
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
por: Stankiewicz Karita, Helen C., et al.
Publicado: (2022) -
A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS‐CoV‐2(−)/(+) populations
por: Steinbronn, Claire, et al.
Publicado: (2023) -
Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study
por: Bershteyn, Anna, et al.
Publicado: (2022) -
LB-17. Efficacy of Hydroxychloroquine (HCQ) for Post-exposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Blinded, Randomized, Controlled Trial
por: Brown, Elizabeth R, et al.
Publicado: (2020) -
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
por: Johnston, Christine, et al.
Publicado: (2021)